Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Nimenrix°°


Contraindicated

No available information
Nimenrix°° :
Type Medicine Withdrawn
Originator B
Agent Food & Drug Corporation
Distributor Food & Drug Corporation
Laboratory Pfizer
Responsible Party Pfizer Ltd
Origin UK
Manufacturer Pfizer Manufacturing Belgium NV
Origin Belgium
ATC J07AH08

Your comment will appear shortly after approval

Nimenrix°° :

Revision Date : 18/07/2014


Effect Frequency
Appetite lost Very Common
Crying Uncommon
Diarrhoea (Diarrhea) Common
Dizziness Uncommon
Drowsiness Very Common
Extensive swelling of vaccinated limb Rare
Fatigue Very Common
Fever Very Common
Gastrointestinal symptom Common
Headache Very Common
Hypoesthesia Uncommon
Injection site anaesthesia Uncommon
Injection site haematoma Common
Injection site induration Uncommon
Injection site pain Very Common
Injection site pruritus Uncommon
Injection site reaction Uncommon
Injection site redness Very Common
Injection site swelling Very Common
Injection site warmth Uncommon
Insomnia Uncommon
Irritability Very Common
Malaise Uncommon
Myalgia Uncommon
Nausea Common
Pain in extremity (Pain in limb) Uncommon
Pruritus Uncommon
Skin rash Uncommon
Vomiting Common

Different Units By MoH Code

Revision Date : 14/05/2012

Nimenrix°°  MoH 9109 :
Form Powder and solvent for solution for injection
Packaging Pre-filled Syringe + Vial
Package Size 1+1x0.5ml
Strength 44µg/5µg/5µg/5µg/5µg
Storage Condition 2-8°C Protect from light. Do not freeze
NSSF ✘
Quarantine ✘
Reg. Number 82517/1
Submission date 01/01/2017
Registration Year 2017
Withdrawn Date 01/08/2023


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info